KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Shares Outstanding (Weighted Average) (2016 - 2025)

Cardlytics' Shares Outstanding (Weighted Average) history spans 10 years, with the latest figure at $53.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 9.83% year-over-year to $53.1 million; the TTM value through Dec 2025 reached $53.1 million, up 9.83%, while the annual FY2025 figure was $53.1 million, 9.83% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $53.1 million in Q4 2025 per CDLX's latest filing, down from $53.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $53.5 million in Q3 2025 to a low of $29.3 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $39.9 million, with a median of $34.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): fell 0.43% in 2023, then surged 43.27% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $32.2 million in 2021, then grew by 3.78% to $33.4 million in 2022, then grew by 9.18% to $36.5 million in 2023, then skyrocketed by 32.54% to $48.4 million in 2024, then rose by 9.83% to $53.1 million in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Shares Outstanding (Weighted Average) are $53.1 million (Q4 2025), $53.5 million (Q3 2025), and $52.3 million (Q2 2025).